Research & Development
Luminopia named Winner at 2026 Digital Health Hub - Digital Health & AI Awards
20 November 2026 -

Luminopia Inc, a digital health company developing a new class of treatments for neuro-visual disorders, announced on Thursday that it has been named a Winner at the 2026 Digital Health Hub – Digital Health & AI Awards, presented by the Digital Health Hub Foundation at HLTH USA 2026 in Las Vegas.

Luminopia won in the Best-in-Class track within the Therapeutics, Pharmacy & Medication Innovation category. Luminopia said this recognition highlights the company's commitment to its mission of treating neuro-visual conditions and its continued efforts to advance healthcare through innovative technologies and solutions.

The Digital Health Hub – Digital Health & AI Awards aim to celebrate organizations developing solutions that address some of healthcare's most pressing challenges, improve patient outcomes, and drive meaningful change across the healthcare ecosystem.

Luminopia's recognition follows clinical and commercial momentum for its FDA-cleared prescription digital therapeutic for amblyopia, the leading cause of vision loss in children. To date, Luminopia has been prescribed to over 15,000 patients by more than 1,600 providers across the country.

Login
Username:

Password: